Clin2
NCT06144970Possibly a fitNot yet recruiting

Gene therapy for chronic back pain from disc degeneration

Degenerative Disc Disease

Part of Bones, joints & muscles clinical trials.

This trial tests an investigational gene therapy injected into the spine for people with long-term low back pain caused by degenerative disc disease. It aims to see if the treatment is safe and tolerable, and whether it can reduce pain and improve function.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
24 people
Ages
22 years to 70 years
Study type
Interventional

Who can take part

  • You are between 22 and 70 years old.
  • You have had chronic low back pain for at least 6 months, and your back pain is noticeably worse than leg pain.
  • Your pain and disability scores are within a moderate-to-severe range (pain 40–90 on a 0–100 scale).
  • You have not gotten enough relief from at least one pain medication and physical therapy for at least 6 months.
  • You have a diagnosis of disc degeneration between the L1 and S1 vertebrae confirmed by MRI, with a Pfirrmann score of 3–7 (moderate to severe).
  • You have a body mass index (BMI) between 15 and 30 and agree to use birth control if applicable.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07254806Recruiting· Phase 3
Cell therapy for low back pain from disc disease

This study tests if injecting a special cell therapy into a damaged spinal disc can reduce chronic low back pain. It is for people who have had low back pain for at least 6 months and haven't gotten enough relief from other treatments like physical therapy or pain medication.

Birmingham, Alabama
NCT05287867Recruiting
Study for painful degenerative disc disease treatment

This trial is testing a treatment approach for people with long-lasting, painful worn-out discs in the lower back (and sometimes leg pain). It looks for people who tried common non-surgical options without enough relief and who may be headed toward a lumbar procedure.

Broomfield, Colorado
NCT06778447Recruiting
Trial of disc tissue injection for degenerative disc disease

This study tests an experimental treatment that injects donated disc tissue (called an allograft) into damaged discs in your lower back. It's designed for people with chronic low back pain from disc degeneration who haven't found relief from non-surgical treatments.

Napa, California
NCT05508360Recruiting
Testing an artificial spacer implant for one-level low back pain

This study tests whether inserting a small artificial implant into a single painful disc can reduce long-term low back pain and disability. It’s for people who tried non-surgical treatments for at least 6 months but still have significant symptoms from degenerative disc disease.

Medellín, Antioquia
NCT07386548Recruiting
Biologic injection for low back disc problems

This study tests if an injection can help people with a herniated disc in the lower back who have not gotten better with other treatments and are already planning surgery. It aims to see if the injection can reduce symptoms and possibly avoid or improve surgery outcomes.

Manhattan, New York
NCT07668466Not yet recruiting· Phase 1/Phase 2
Injecting a growth factor for low back pain from worn discs

This trial tests an injection of a protein called rhGDF-6 that may help repair damaged spinal discs and reduce low back pain. If you have chronic back pain from one or two degenerated discs, this treatment might be an option if other treatments haven't helped enough.

Kogarah, New South Wales

Hear when a new Degenerative Disc Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.